Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,554 | 50,211 | 55,736 | 78,442 | 37,866 |
| Receivables | 37,785 | 38,309 | 33,223 | 26,689 | 26,551 |
| TOTAL | $84,930 | $91,904 | $92,241 | $107,946 | $67,845 |
| Non-Current Assets | |||||
| PPE Net | 3,762 | 3,999 | 4,009 | 3,337 | 3,496 |
| Intangibles | 107,423 | 110,074 | 112,214 | 78,794 | 79,271 |
| Other Non-Current Assets | 1,196 | 1,291 | 1,407 | 1,271 | 1,906 |
| TOTAL | $112,381 | $115,364 | $117,630 | $83,402 | $84,673 |
| Total Assets | $197,311 | $207,268 | $209,871 | $191,348 | $152,518 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,626 | 9,128 | 8,269 | 7,627 | 8,555 |
| Accrued Expenses | 8,045 | 12,035 | 9,416 | 7,737 | 7,925 |
| Other current liabilities | 305 | 305 | 326 | 624 | 746 |
| TOTAL | $41,120 | $53,559 | $56,363 | $42,768 | $39,870 |
| Non-Current Liabilities | |||||
| Long Term Debt | 53 | 131 | 227 | 325 | 4,918 |
| Deferred Revenues | 9,032 | 9,648 | 9,795 | 9,470 | 9,457 |
| TOTAL | $5,346 | $5,089 | $5,393 | $5,613 | $10,793 |
| Total Liabilities | $46,466 | $58,648 | $61,756 | $48,381 | $50,663 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,311 | 37,744 | 37,878 | 37,344 | 37,180 |
| Common Shares | 4 | 4 | 4 | 4 | 3 |
| Retained earnings | -52,632 | -53,757 | -55,684 | -56,265 | -56,603 |
| Other shareholders' equity | 10,025 | 10,792 | 10,878 | 10,322 | 10,546 |
| TOTAL | $150,845 | $148,620 | $148,115 | $142,967 | $101,855 |
| Total Liabilities And Equity | $197,311 | $207,268 | $209,871 | $191,348 | $152,518 |